突发性耳聋患者HMGBl和ENA-78含量在治疗前后变化的意义

摘要

Objective To study the role and clinical significance of serum high mobility group box -1 ( HMGB1) and epithelial neutrophil-activing peptide-78( ENA-78) in idiopathic sudden sensorineural hearing loss by measuring the change of their levels in the patients with idiopathic sudden sensorineural hearing loss . Methods The levels HMGB1 and ENA-78 were determined by ELISA method in the 102 idiopathic sudden sensorineural hearing loss patients who were observed at two different time points : before and after treatment,and thirty-five patients with other neurologic diseases ( 20 with sciatica,16 with trigeminal neuralgia ) and thirty healthy people were used as control. Results The levels HMGB1 and ENA-78 in serum of patients with idiopathic sudden sensorineural hearing loss were markedly higher than those in the two control groups (P ＜ 0. 01 ) ; The levels of HMGB1 and ENA-78 in the idiopathic sudden sensorineural hearing loss group after treatment were significantly less than that before treatment (P ＜0. 01 ). There was a correlation between HMGB1 and ENA-78 in patients with idiopathic sudden sensorineural hearing loss (r =0. 68, P ＜ 0. 01 )Conclusions The levels of serum HMGB1 and ENA-78 have instructive significance in idiopathic sudden sensorineural hearing loss treating and prognosis estimating .%目的 探讨突发性耳聋患者血清高迁移率蛋白-1(HMGB1)和中性粒细胞激活肽-78(ENA-78)的含量变化,及其在突发性耳聋发生过程中的作用和意义.方法 采用酶联免疫(ELISA)法检测血清HMGB1和ENA-78含量;检测102例突发性耳聋患者、35例其他疾病对照组和30例健康对照组的血清HMGB1和ENA-78含量,并比较治疗前后血清HMGB1和ENA-78的测定结果 .结果 突发性耳聋患者治疗前血清HMGB1和ENA-78含量较两对照组显著升高(P<0.01);治疗后患者HMGB1和ENA-78含量明显降低.同时重度组突发性耳聋患者血清HMGB1和ENA-78浓度明显高于中、轻度组,中度组患者明显高于轻度组,且差异有统计学意义(P<0.01).突发性耳聋患者血清HMGB1和ENA-78含量之间呈正相关(r=0.68,P<0.01).结论 血清HMGB1和ENA-78水平的变化与突发性耳聋病情严重程度密切相关.